United Therapeutics (UTHR) EV to FCF (2009 - 2026)

United Therapeutics has disclosed EV to FCF across 18 years of filings, most recently posting 99.52 for Q2 2026.

• In Q2 2026, EV to FCF rose 29.61% year-over-year to 99.52; the TTM figure through Jun 2026 stood at 18.72 (up 101.63% YoY), while the FY2025 annual figure was 17.63, up 51.76% from the prior year.
• EV to FCF came in at 99.52 for Q2 2026 at United Therapeutics, up from 63.02 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 124.63 in Q2 2023 to a low of 21.28 in Q1 2022.
• Average EV to FCF over 5 years is 61.84, with a median of 54.53 recorded in 2024.
• Year-over-year, EV to FCF sank 70.74% in 2022 and jumped 130.23% in 2026.
• Over 5 years, EV to FCF stood at 112.32 in 2022, then dropped by 9.11% to 102.08 in 2023, then plunged by 51.69% to 49.32 in 2024, then soared by 114.64% to 105.86 in 2025, then decreased by 5.99% to 99.52 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 99.52 in Q2 2026, 63.02 in Q1 2026, and 105.86 in Q4 2025.